Actavis completes acquisition of Forest Laboratories
Creates an innovative new model in speciality pharma leadership
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Merck Serono’s grants programme to fund scientific innovation
The programme combines grants portfolio with annual €20 million investment to advance innovation and medical education
Bharat Biotech donates REGEN-D to victims of AP gas explosion
Donates 500 tubes of REGEN-D to AP CM’s Relief Fund
Glenmark Generics receives ANDA approval
Telmisartan is Glenmark’s generic version of Boehringer Ingelheim’s Micardis
Focus on complementary products to develop existing portfolio drives M&A activity
M&A activity in the pharmaceutical sector was focused on advancing the development of promising products through complementary…
Conference on ‘Innovations in Oral Drug Delivery Systems’ held in Mumbai
Organised by Infinity Business Services and supported by I3R Global, the conference aimed to highlight the latest trends and…
Glenmark plans manufacturing facility in US
The facility will manufacture oral solids, injectables and topicals over a five year period
MPP signs seven sub-licensing agreements to manufacture HIV medicines
Forges first agreement with Desano, Cipla, Mylan, Micro Labs and extends collaborations with Aurobindo, Laurus Labs and Emcure
Cryoport partners with DHL
To provide cryogenic logistics solutions for life sciences and healthcare clients